Showing 1 - 20 results of 267 for search '"Biological Products therapeutic use"', query time: 1.09s Refine Results
1
The cost burden of Crohn's disease and ulcerative colitis depending on biologic treatment status - a Danish register-based study

Authors: Alulis, Sarah, Vadstrup, Kasper, Olsen, Jens, Jørgensen, Tine Rikke, Qvist, Niels, Munkholm, Pia, Borsi, Andras

Source: Alulis, S, Vadstrup, K, Olsen, J, Jørgensen, T R, Qvist, N, Munkholm, P & Borsi, A 2021, ' The cost burden of Crohn's disease and ulcerative colitis depending on biologic treatment status-a Danish register-based study ', BMC Health Services Research, vol. 21, 836 . https://doi.org/10.1186/s12913-021-06816-3
BMC Health Services Research, Vol 21, Iss 1, Pp 1-9 (2021)
BMC Health Services Research
Alulis, S, Vadstrup, K, Olsen, J, Jørgensen, T R, Qvist, N, Munkholm, P & Borsi, A 2021, ' The cost burden of Crohn’s disease and ulcerative colitis depending on biologic treatment status – a Danish register-based study ', BMC Health Services Research, vol. 21, no. 1 . https://doi.org/10.1186/s12913-021-06816-3

Subject Terms: Biological Products/therapeutic use, Colitis, Ulcerative/drug therapy, Crohn Disease/drug therapy, Denmark/epidemiology, Humans, Inflammatory Bowel Diseases, CD, IBD, Epidemiology, UC, Health economy, National register data, Societal burden, Public aspects of medicine, RA1-1270, Health Policy, Research Article, Journal Article

File Description: application/pdf

Access URL: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::95b2c62db81d45b07048700bba147c2c
https://findresearcher.sdu.dk:8443/ws/files/190687859/s12913_021_06816_3.pdf

2
Risk of serious infections in arthritis patients treated with biological drugs:a matched cohort study and development of prediction model

Authors: Kathrine Lederballe Grøn, Frank Mehnert, Mikkel Østergaard, Simon Krabbe, Dorte Ejg Jarbøl, Merete Lund Hetland, Mette Nørgaard, Bente Glintborg

Source: Krabbe, S, Grøn, K L, Glintborg, B, Nørgaard, M, Mehnert, F, Jarbøl, D E, Østergaard, M & Hetland, M L 2021, ' Risk of serious infections in arthritis patients treated with biological drugs : a matched cohort study and development of prediction model ', Rheumatology (Oxford, England), vol. 60, no. 8, pp. 3834-3844 . https://doi.org/10.1093/rheumatology/keaa876
Krabbe, S, Grøn, K L, Glintborg, B, Nørgaard, M, Mehnert, F, Jarbøl, D E, Østergaard, M & Hetland, M L 2021, ' Risk of serious infections in arthritis patients treated with biological drugs : a matched cohort study and development of prediction model ', Rheumatology, vol. 60, no. 8, pp. 3834-3844 . https://doi.org/10.1093/rheumatology/keaa876

Subject Terms: biologicals, epidemiology, infection, Area Under Curve, Humans, Middle Aged, Arthritis, Rheumatoid/drug therapy, Male, Arthritis, Psoriatic/drug therapy, Case-Control Studies, Spondylarthropathies/drug therapy, Tumor Necrosis Factor Inhibitors/therapeutic use, Adult, Female, Ustekinumab/therapeutic use, Clinical Decision Rules, Severity of Illness Index, Antibodies, Monoclonal, Humanized/therapeutic use, Proportional Hazards Models, Logistic Models, Hospitalization, Biological Products/therapeutic use, Infections/epidemiology, ROC Curve, Aged, Antirheumatic Agents/therapeutic use, Rituximab/therapeutic use, Cohort Studies, Pharmacology (medical), Rheumatology, Arthritis, medicine.disease, medicine, Logistic regression, Confidence interval, Internal medicine, medicine.medical_specialty, business.industry, business, Framingham Risk Score, Hazard ratio, Population, education.field_of_study, education, Psoriatic arthritis, Proportional hazards model

Access URL: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::488ef68537652c680c0490daf788a33f
https://portal.findresearcher.sdu.dk/da/publications/a09b27dd-2484-4c07-b37f-190e5d3504b7

4
The ethical implications of utilizing advertising techniques to increase biologic treatment willingness in patients with psoriasis

Authors: Bray, Jeremy K., Feldman, Steven R.

Source: Bray, J K & Feldman, S R 2020, ' The ethical implications of utilizing advertising techniques to increase biologic treatment willingness in patients with psoriasis ', Dermatology Online Journal, vol. 26, no. 7, 15 . < https://escholarship.org/uc/item/5448w3rz#main >

Subject Terms: Dermatology, General Medicine, Adherence, Advertising, Biologics, Ethics, Marketing, Psoriasis, Psychology, Treatment, Ethics, Medical, Humans, Psoriasis/drug therapy, Advertising/ethics, Biological Products/therapeutic use, Informed Consent, Medication Adherence

File Description: application/pdf

Access URL: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::69568487cac0e046e57f8a7794596084

5
Individualized home-monitoring of disease activity in adult patients with inflammatory bowel disease can be recommended in clinical practice: A randomized-clinical trial

Authors: Kristine Paridaens, Mette Bennedsen, Dorte Marker, Sanaz Saboori, Petra Weimers, Johan Burisch, Pia Munkholm, Dorit Vedel Ankersen

Source: Ankersen, D V, Weimers, P, Marker, D, Bennedsen, M, Saboori, S, Paridaens, K, Burisch, J & Munkholm, P 2019, ' Individualized home-monitoring of disease activity in adult patients with inflammatory bowel disease can be recommended in clinical practice : A randomized-clinical trial ', World Journal of Gastroenterology, vol. 25, no. 40, pp. 6158-6171 . https://doi.org/10.3748/wjg.v25.i40.6158
World Journal of Gastroenterology

Subject Terms: Gastroenterology, General Medicine, Internal medicine, medicine.medical_specialty, medicine, Randomized controlled trial, law.invention, law, business.industry, business, eHealth, Screening procedures, Interquartile range, Calprotectin, Disease, Inflammatory bowel disease, medicine.disease, Quality of life, Adult, Biological Products/therapeutic use, Colitis, Ulcerative/diagnosis, Crohn Disease/diagnosis, Disease Progression, Feces/chemistry, Female, Glucocorticoids/therapeutic use, Humans, Immunologic Factors/therapeutic use, Internet-Based Intervention, Leukocyte L1 Antigen Complex/analysis, Male, Mass Screening/instrumentation, Medication Adherence, Middle Aged, Program Evaluation, Quality of Life, Recurrence, Severity of Illness Index, Telemedicine/instrumentation, Journal Article, Randomized Controlled Trial, Randomized Clinical Trial, Electronic health, Screening, Disease activity

File Description: application/pdf

Access URL: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::795233df9710c57fcb400c53e233ffc4
https://www.wjgnet.com/1007-9327/full/v25/i40/6158.htm

6
Comparison of the sensitivity of patient-reported outcomes for detecting the benefit of biologics in severe asthma

Authors: Michael E Hyland, Joseph W Lanario, Andrew Menzies-Gow, Adel H Mansur, James W Dodd, Stephen J Fowler, Gemma Hayes, Rupert C Jones, Matthew Masoli

Source: Hyland, M E, Lanario, J W, Menzies-Gow, A, Mansur, A H, Dodd, J W, Fowler, S J, Hayes, G, Jones, R C & Masoli, M 2021, ' Comparison of the sensitivity of patient-reported outcomes for detecting the benefit of biologics in severe asthma ', Chronic Respiratory Disease, vol. 18 . https://doi.org/10.1177/14799731211043530
Chronic Respiratory Disease

Subject Terms: Pulmonary and Respiratory Medicine, Original Paper, Asthma, quality of life, measurement, Severe Asthma Questionnaire, Asthma Control Questionnaire-6, EQ5D, Asthma/drug therapy, Biological Products/therapeutic use, Humans, Patient Reported Outcome Measures, Prospective Studies, Psychometrics, Quality of Life, Retrospective Studies, Surveys and Questionnaires

File Description: application/pdf

Access URL: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::26e93132652b2a32df51359d18b33417
http://journals.sagepub.com/doi/pdf/10.1177/14799731211043530

7
Reply to: Biological Therapy in Patients with Rheumatoid Arthritis in a Tertiary Center in Portugal: A Cross-Sectional Study

Authors: Joana Ramos Rodrigues, Daniela Santos-Faria, Carmo Afonso, José Tavares-Costa

Source: Acta Médica Portuguesa, Vol 34, Iss 7-8, Pp 562-562 (2021)

Subject Terms: General Medicine, arthritis, rheumatoid/drug therapy, biological products/therapeutic use, biological therapy, Medicine, Medicine (General), R5-920

Access URL: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::117a4dac7c2dd4fe25a4ce7480fa205d
https://actamedicaportuguesa.com/revista/index.php/amp/article/viewFile/16513/6383

10
EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies:2019 update

Authors: Andreas Kerschbaumer, Georg Schett, Denis Poddubnyy, Gerd R Burmester, Jette Primdahl, Peter V. Balint, Maarten de Wit, Wolf-Henning Boehncke, Robert Landewé, Iain B. McInnes, Laure Gossec, Maxime Dougados, Daniel Aletaha, Juan D. Cañete, Xenofon Baraliakos, Tore K Kvien, Nemanja Damjanov, Rik Jozef Urbain Lories, Andra Balanescu, Filip Van den Bosch, Santiago Andres Rodrigues Manica, Heidi Bertheussen, Josef S Smolen, Helena Marzo-Ortega, Désirée van der Heijde, Douglas J. Veale, Dennis McGonagle, Tue Wenzel Kragstrup

Contributors: Clinical Immunology and Rheumatology, AII - Inflammatory diseases

Source: Gossec, L, Baraliakos, X, Kerschbaumer, A, de Wit, M, McInnes, I, Dougados, M, Primdahl, J, McGonagle, D G, Aletaha, D, Balanescu, A, Balint, P V, Bertheussen, H, Boehncke, W-H, Burmester, G R, Canete, J D, Damjanov, N S, Kragstrup, T W, Kvien, T K, Landewé, R B M, Lories, R J U, Marzo-Ortega, H, Poddubnyy, D, Rodrigues Manica, S A, Schett, G, Veale, D J, Van den Bosch, F E, van der Heijde, D & Smolen, J S 2020, ' EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies : 2019 update ', Annals of the Rheumatic Diseases, vol. 79, no. 6, pp. 700-712 . https://doi.org/10.1136/annrheumdis-2020-217159
Gossec, L, Baraliakos, X, Kerschbaumer, A, de Wit, M, McInnes, I, Dougados, M, Primdahl, J, McGonagle, D G, Aletaha, D, Balanescu, A, Balint, P V, Bertheussen, H, Boehncke, W H, Burmester, G R, Canete, J D, Damjanov, N S, Kragstrup, T W, Kvien, T K, Landewé, R B M, Lories, R J U, Marzo-Ortega, H, Poddubnyy, D, Rodrigues Manica, S A, Schett, G, Veale, D J, Van den Bosch, F E, van der Heijde, D & Smolen, J S 2020, ' EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies : 2019 update ', Annals of the rheumatic diseases, vol. 79, no. 6, pp. 700-712 . https://doi.org/10.1136/annrheumdis-2020-217159
Annals of the Rheumatic Diseases, Vol. 79, No 6 (2020) pp. 700-712
ANNALS OF THE RHEUMATIC DISEASES
Annals of the rheumatic diseases, 79(6), S700-S712. BMJ Publishing Group
Annals of the Rheumatic Diseases

Subject Terms: DMARDs (biologic), psoriatic arthritis, treatment, ddc:616, Anti-Inflammatory Agents, Non-Steroidal/therapeutic use, Arthritis, Psoriatic/drug therapy, Biological Products/therapeutic use, Consensus, Consensus Development Conferences as Topic, Decision Making, Shared, Europe, Glucocorticoids/therapeutic use, Humans, Interleukin-12/antagonists & inhibitors, Interleukin-17/antagonists & inhibitors, Interleukin-23/antagonists & inhibitors, Janus Kinase Inhibitors/therapeutic use, Phosphodiesterase 4 Inhibitors/therapeutic use, Societies, Medical, Synthetic Drugs/therapeutic use, Systematic Reviews as Topic, Tumor Necrosis Factor-alpha/antagonists & inhibitors, Biology and Life Sciences, Medicine and Health Sciences, MODIFYING ANTIRHEUMATIC DRUG, RANDOMIZED CONTROLLED-TRIAL, PLACEBO-CONTROLLED TRIAL, RHEUMATOID-ARTHRITIS, DOUBLE-BLIND, ANKYLOSING-SPONDYLITIS, DISEASE-ACTIVITY, PHASE-III, EXTRAARTICULAR, MANIFESTATIONS, CLINICAL CHARACTERISTICS, Immunology and Allergy, Rheumatology, Immunology, Biochemistry, Genetics and Molecular Biology(all), General Biochemistry, Genetics and Molecular Biology, Polyarthritis, medicine.disease, medicine, Intensive care medicine, medicine.medical_specialty, Oligoarthritis, Psoriatic arthritis, Dactylitis, Evidence-based medicine, business.industry, business, TNF inhibitor, medicine.medical_treatment, Rheumatoid arthritis, Biochemistry, Genetics and Molecular Biology(all), Recommendation, Science & Technology, Life Sciences & Biomedicine, EXTRAARTICULAR MANIFESTATIONS

File Description: application/pdf; Print

Access URL: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a77d4a94d305a2a0200306e83597745
https://pure.au.dk/ws/files/220257044/700.1.full.pdf

14
Pharmacovigilance in juvenile idiopathic arthritis patients treated with biologic or synthetic drugs : Combined data of more than 15,000 patients from Pharmachild and national registries

Authors: Joost Swart, Gabriella Giancane, Gerd Horneff, Bo Magnusson, Michael Hofer, Еkaterina Alexeeva, Violeta Panaviene, Brigitte Bader-Meunier, Jordi Anton, Susan Nielsen, Fabrizio De Benedetti, Sylvia Kamphuis, Valda Staņēviča, Maria Tracahana, Laura Marinela Ailioaie, Elena Tsitsami, Ariane Klein, Kirsten Minden, Ivan Foeldvari, Johannes Peter Haas, Jens Klotsche, Anna Carin Horne, Alessandro Consolaro, Francesca Bovis, Francesca Bagnasco, Angela Pistorio, Alberto Martini, Nico Wulffraat, Nicolino Ruperto, for the Paediatric Rheumatology International Trials Organisation (PRINTO), BiKeR and the board of the Swedish Registry

Contributors: Department of Pediatrics, Paediatric Rheumatology International Trials Organisation (PRINTO), BiKeR and the board of the Swedish Registry

Source: Arthritis Research & Therapy, Vol 20, Iss 1, Pp 1-11 (2018)
Arthritis research & therapy, vol. 20, no. 1, pp. 285
Arthritis Research & Therapy
Arthritis research & therapy, 20(1). BioMed Central
Arthritis Research & Therapy 20(1) 285
Arthritis research and therapy, London : BioMed Central Ltd., 2018, vol. 20, iss. 1, art. no. 285, p. [1-11]

Subject Terms: Juvenile idiopathic arthritis, Registry, Safety, Adverse events, Methotrexate, Biologics, Rheumatology, Immunology and Allergy, Immunology, Journal Article, lcsh:Diseases of the musculoskeletal system, lcsh:RC925-935, Adverse events, Biologics, Juvenile idiopathic arthritis, Methotrexate, Registry, Safety, Adolescent, Antirheumatic Agents/adverse effects, Antirheumatic Agents/therapeutic use, Arthritis, Juvenile/diagnosis, Arthritis, Juvenile/drug therapy, Biological Products/adverse effects, Biological Products/therapeutic use, Child, Child, Preschool, Drug Monitoring, Etanercept/adverse effects, Etanercept/therapeutic use, Female, Humans, Male, Methotrexate/adverse effects, Methotrexate/therapeutic use, Pharmacovigilance, Prospective Studies, Registries/statistics & numerical data, Retrospective Studies, Synthetic Drugs/adverse effects, Synthetic Drugs/therapeutic use, Treatment Outcome, Research Article, Internal medicine, medicine.medical_specialty, medicine, Polyarthritis, medicine.disease, business.industry, business, Etanercept, medicine.drug, Arthritis, Adverse effect, Pharmacoepidemiology, Synthetic drugs

File Description: application/pdf; image/pdf

Access URL: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2bcdd4ca65f29113be02f5af41fcde07

15
Impacto dos Agentes Biológicos em Doentes com Artrite Reumatóide

Authors: Sá, Ana, Freitas, Sara, Alves, Glória, Cotter, Jorge

Source: Medicina Interna, Volume: 25, Issue: 3, Pages: 201-207, Published: SEP 2018

Subject Terms: Antirreumáticos/uso terapêutico, Artrite Reumatóide/tratamento, Biológicos/uso terapêutico, Etanercept, Receptores do Fator de Necrose Tumoral, Antirheumatic Agents/therapeutic use, Arthritis, Rheumatoid/drug therapy, Biological Products/therapeutic use, Receptors, Tumor Necrosis Factor

File Description: text/html

Access URL: https://explore.openaire.eu/search/publication?articleId=od_______616::096211c12e953b738c08850fd2c0a5f1
http://www.scielo.mec.pt/scielo.php?script=sci_arttext&pid=S0872-671X2018000300009&lng=en&tlng=en

16
Role of Vitamin D in the Natural History of Inflammatory Bowel Disease

Authors: Nielsen, Ole Haagen, Rejnmark, Lars, Moss, Alan C

Source: Nielsen, O H, Rejnmark, L & Moss, A C 2018, ' Role of Vitamin D in the Natural History of Inflammatory Bowel Disease ', Journal of Crohn's & colitis, vol. 12, no. 6, pp. 742-752 . https://doi.org/10.1093/ecco-jcc/jjy025

Subject Terms: Adaptive Immunity, Biological Products/therapeutic use, Dietary Supplements, Humans, Immunity, Innate, Inflammatory Bowel Diseases/complications, Receptors, Calcitriol/immunology, Vitamin D/analogs & derivatives, Vitamin D Deficiency/complications, Gastroenterology, General Medicine, Antimicrobial peptide secretion, Immune system, vitamin D deficiency, medicine.disease, medicine, Calcitriol receptor, Regulatory T cell, medicine.anatomical_structure, business.industry, business, Ulcerative colitis, Vitamin D and neurology, Inflammatory bowel disease, Immunology, digestive system diseases

Access URL: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f9586275c4c6f4382d5bbe6f56df4a6a
https://pure.au.dk/portal/da/publications/role-of-vitamin-d-in-the-natural-history-of-inflammatory-bowel-disease(bef9d46b-be9a-4be1-8c99-471e6b2034ac).html

17
Association between NICE guidance on biologic therapies with rates of hip and knee replacement among rheumatoid arthritis patients in England and Wales:An interrupted time-series analysis

Authors: René Cordtz, Daniel Prieto-Alhambra, Lene Dreyer, Samuel Hawley, Alan J. Silman, Nigel K. Arden, Antonella Delmestri, Andrew Judge, Christopher J. Edwards, Cyrus Cooper

Source: Hawley, S, Cordtz, R, Dreyer, L, Edwards, C J, Arden, N K, Delmestri, A, Silman, A, Cooper, C, Judge, A & Prieto-Alhambra, D 2018, ' Association between NICE guidance on biologic therapies with rates of hip and knee replacement among rheumatoid arthritis patients in England and Wales : An interrupted time-series analysis. ', Seminars in Arthritis and Rheumatism, vol. 47, no. 5, pp. 605-610 . https://doi.org/10.1016/j.semarthrit.2017.09.006
Hawley, S, Cordtz, R, Dreyer, L, Edwards, C J, Arden, N K, Delmestri, A, Silman, A, Cooper, C, Judge, A & Prieto-Alhambra, D 2018, ' Association between NICE guidance on biologic therapies with rates of hip and knee replacement among rheumatoid arthritis patients in England and Wales : An interrupted time-series analysis ', Seminars in Arthritis and Rheumatism, vol. 47, no. 5, pp. 605-610 . https://doi.org/10.1016/j.semarthrit.2017.09.006

Subject Terms: Pharmacoepidemiology, rheumatoid arthritis, biologic therapy, arthroplasty of hip, athroplasty of knee, Anesthesiology and Pain Medicine, Rheumatology, Nice, computer.programming_language, computer, Medicine, business.industry, business, Nice guidance, Biologic therapies, Rheumatoid arthritis, medicine.disease, Correlation and dependence, Knee replacement, medicine.medical_treatment, Internal medicine, medicine.medical_specialty, Interrupted Time Series Analysis, Surgery, Antirheumatic Agents/therapeutic use, Arthritis, Rheumatoid/drug therapy, Arthroplasty, Replacement, Hip/statistics & numerical data, Arthroplasty, Replacement, Knee/statistics & numerical data, Biological Products/therapeutic use, England, Female, Humans, Male, Middle Aged, Wales, Journal Article, Research Support, Non-U.S. Gov't, Article

File Description: application/pdf; text

Access URL: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::90518098321f7376cbc54e1fe9fac757
https://research-information.bris.ac.uk/ws/files/185055915/1_s2.0_S0049017217303104_main.pdf

18
When does atopic dermatitis warrant systemic therapy? Recommendations from an expert panel of the International Eczema Council

Authors: Simpson, E.L., Bruin-Weller, M., Flohr, C., Ardern-Jones, M.R., Barbarot, S., Deleuran, M., Bieber, T., Vestergaard, C., Brown, S.J., Cork, M.J., Drucker, A.M., Eichenfield, L.F., Foelster-Holst, R., Guttman-Yassky, E., Nosbaum, A., Reynolds, N.J., Silverberg, J.I., Schmitt, J., Seyger, M.M.B., Spuls, P.I., Stalder, J.-F., Su, J.C., Takaoka, R., Traidl-Hoffmann, C., Thyssen, J.P., van der Schaft, J., Wollenberg, A., Irvine, A.D., Paller, A.S.

Contributors: APH - Methodology, APH - Quality of Care, AII - Inflammatory diseases, Dermatology, Amsterdam institute for Infection and Immunity

Source: Journal of the American Academy of Dermatology, 77(4), 623. Mosby Inc.
Journal of the American Academy of Dermatology, 77(4), 623-633. Mosby Inc.
Simpson, E L, Bruin-Weller, M, Flohr, C, Ardern-Jones, M R, Barbarot, S, Deleuran, M, Bieber, T, Vestergaard, C, Brown, S J, Cork, M J, Drucker, A M, Eichenfield, L F, Foelster-Holst, R, Guttman-Yassky, E, Nosbaum, A, Reynolds, N J, Silverberg, J I, Schmitt, J, Seyger, M M B, Spuls, P I, Stalder, J-F, Su, J C, Takaoka, R, Traidl-Hoffmann, C, Thyssen, J P, van der Schaft, J, Wollenberg, A, Irvine, A D & Paller, A S 2017, ' When does atopic dermatitis warrant systemic therapy? Recommendations from an expert panel of the International Eczema Council ', Journal of the American Academy of Dermatology, pp. 623-633 . https://doi.org/10.1016/j.jaad.2017.06.042
Simpson, E L, Bruin-Weller, M, Flohr, C, Ardern-Jones, M R, Barbarot, S, Deleuran, M, Bieber, T, Vestergaard, C, Brown, S J, Cork, M J, Drucker, A M, Eichenfield, L F, Foelster-Holst, R, Guttman-Yassky, E, Nosbaum, A, Reynolds, N J, Silverberg, J I, Schmitt, J, Seyger, M M B, Spuls, P I, Stalder, J-F, Su, J C, Takaoka, R, Traidl-Hoffmann, C, Thyssen, J P, van der Schaft, J, Wollenberg, A, Irvine, A D & Paller, A S 2017, ' When does atopic dermatitis warrant systemic therapy? Recommendations from an expert panel of the International Eczema Council ', Journal of the American Academy of Dermatology, vol. 77, no. 4, pp. 623-633 . https://doi.org/10.1016/j.jaad.2017.06.042
Journal of the American Academy of Dermatology, 77, 623-633

Subject Terms: Administration, Cutaneous, Oral, Biological Products, Clinical Decision-Making, Dermatitis, Atopic, Dermatologic Agents, Humans, Immunosuppressive Agents, Injections, Patient Education as Topic, Phototherapy, Quality of Life, Severity of Illness Index, Consensus Development Conference, Journal Article, Dermatology, Administration, Cutaneous, Administration, Oral, Dermatitis, Atopic, Biological Products/therapeutic use, Dermatitis, Atopic/diagnosis, Dermatologic Agents/administration & dosage, Immunosuppressive Agents/administration & dosage, atopic dermatitis, azathioprine, biologic, consensus statement, cyclosporine, eczema, methotrexate, systemic therapy, Alternative medicine, medicine.medical_specialty, medicine, Topical medication, Position paper, Intensive care medicine, Quality of life, business.industry, business, SCORAD, medicine.diagnostic_test, Atopic dermatitis, medicine.disease, Severity of illness, Systemic therapy

File Description: image/pdf; application/pdf; text

Access URL: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e4c2f07f07f386af5d91d29b526bc4f

19
eBook
Asthma: Targeted Biological Therapies

Authors: Girolamo Pelaia, Alessandro Vatrella, Rosario Maselli

Resource Type: eBook.

Subjects: Personalized medicine, Asthma--Treatment, Biological products--Therapeutic use

Categories: MEDICAL / Pulmonary & Thoracic Medicine, MEDICAL / Family & General Practice, MEDICAL / Immunology, MEDICAL / Pediatrics, MEDICAL / Pharmacology

20
Incidence of hip and knee replacement in patients with rheumatoid arthritis following the introduction of biological DMARDs: an interrupted time-series analysis using nationwide Danish healthcare registers

Authors: Cordtz, R, Hawley, S, Prieto-Alhambra, D, Højgaard, P, Zobbe, K, Overgaard, S, Odgaard, A, Kristensen, LE, Dreyer, L

Source: Cordtz, R L, Hawley, S, Prieto-Alhambra, D, Højgaard, P, Zobbe, K, Overgaard, S, Odgaard, A, Kristensen, L E & Dreyer, L 2018, ' Incidence of hip and knee replacement in patients with rheumatoid arthritis following the introduction of biological DMARDs : an interrupted time-series analysis using nationwide Danish healthcare registers ', Annals of the Rheumatic Diseases, vol. 77, no. 5, pp. 684-689 . https://doi.org/10.1136/annrheumdis-2017-212424

Subject Terms: General Biochemistry, Genetics and Molecular Biology, Immunology, Immunology and Allergy, Rheumatology, Medicine, business.industry, business, Cohort study, Cohort, Rheumatoid arthritis, medicine.disease, Knee replacement, medicine.medical_treatment, Orthopedic surgery, medicine.medical_specialty, Population, education.field_of_study, education, Internal medicine, Incidence (epidemiology), Epidemiology, Journal Article, dmards (biologic), epidemiology, orthopedic surgery, rheumatoid arthritis, anti-TNF, Arthroplasty, Replacement, Hip/statistics & numerical data, Interrupted Time Series Analysis, Humans, Middle Aged, Arthritis, Rheumatoid/drug therapy, Male, Biological Products/therapeutic use, Incidence, Arthroplasty, Replacement, Knee/statistics & numerical data, Denmark, Adult, Female, Registries, Aged, Antirheumatic Agents/therapeutic use, Cohort Studies

Access URL: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a1a92a3d08801b539427a28334b8448a

Search Tools: Get RSS Feed — Email this Search